Is the U.S. making progress on a Zika vaccine?Already, HHS has awarded around $433 million for Zika response and preparedness activities. In addition, the new Senate and House budget, passed in late September, contained $1.1 billion in Zika funding.
Pharmacists’ role in administering vaccinations on the increaseThe number of pharmacists providing vaccinations – both in the U.S. and around the world – is growing significantly.
Risky antibiotic use threatens patientsPatients are willing to use antibiotics without contacting a medical professional, according to a study published in Antimicrobial Agents and Chemotherapy.
Oral Anticoagulant Safety, Apixaban, Statins and VTEAccording to a recent report from the Institute of Safe Medication practices (ISMP), FDA received 34,765 adverse drug event reports for oral anticoagulants in 2015.
New dosage form for migraine treatmentFDA approved Onzetra Xsail (Avanir Pharmaceuticals Inc.)— a fast-acting, low-dose sumatriptan dry powder formulation for the acute treatment of migraine with or without aura in adults.
Pharmacists help to combat meningococcal diseaseAs bacterial meningitis spikes in certain regions of the U.S. and with more schools recommending vaccination, some pharmacy chains are helping to combat the disease.
Top vaccination errors—and how to avoid them
Study: Biosimilars as safe as branded drugsNew study finds that biosimilar medications for arthritis and other diseases areas safe and effective as their brand-name counterparts.
Why pharmacists are concerned about the safety of biosimilarsPharmacists and other healthcare professionals are looking to the FDA for more guidance on biosimilars and interchangeability with their reference products.
Inside the U.S., European markets for biosimilarsDespite barriers to their adoption in the U.S. and Europe, biosimilars have produced healthcare savings in Europe. Similar savings are projected for the U.S. market.